LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Tilray Inc

Geschlossen

BrancheGesundheitswesen

0.4 2.56

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.38

Max

0.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

-708M

-794M

Verkäufe

-118M

186M

EPS

-0.869

Gewinnspanne

-427.136

Angestellte

2,650

EBITDA

-585M

-626M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+138.46% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

28. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-615M

414M

Vorheriger Eröffnungskurs

-2.16

Vorheriger Schlusskurs

0.4

Nachrichtenstimmung

By Acuity

51%

49%

316 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Tilray Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Apr. 2025, 12:06 UTC

Market Talk

Tilray Reckons Sales Won't Be Dented by Tariffs -- Market Talk

Peer-Vergleich

Kursveränderung

Tilray Inc Prognose

Kursziel

By TipRanks

138.46% Vorteil

12-Monats-Prognose

Durchschnitt 0.93 USD  138.46%

Hoch 1.5 USD

Tief 0.6 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tilray Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

2

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

0.421 / 0.4898Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

316 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tilray Inc

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.